` 4DX (4DMedical Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

4DX
vs
S&P/ASX 300

Over the past 12 months, 4DX has underperformed S&P/ASX 300, delivering a return of -59% compared to the S&P/ASX 300's 8% growth.

Stocks Performance
4DX vs S&P/ASX 300

Loading

Performance Gap
4DX vs S&P/ASX 300

Loading
4DX
S&P/ASX 300
Difference

Performance By Year
4DX vs S&P/ASX 300

Loading
4DX
S&P/ASX 300
Add Stock

Competitors Performance
4DMedical Ltd vs Peers

S&P/ASX 300
4DX
VEEV
PME
DOCS
2413
Add Stock

4DMedical Ltd
Glance View

Market Cap
103.3m AUD
Industry
Health Care

4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-08-07. The firm is focused on development of a non-invasive respiratory imaging solution using four-dimensional imaging. The firm's XV Technology is a four-dimensional lung imaging technology that utilizes mathematical models and algorithms to convert X-ray scans into quantitative data for physicians to manage patients with respiratory diseases and diseases of the lung. The XV Technology is accessible through a cloud-based software as a service (SaaS) platform that integrates with existing hospital equipment. The XV Technology Lung Ventilation Analysis Software (XV LVAS Ventilation) provides a non-invasive way of understanding regional lung motion and airflow. The company enables physicians to detect areas of high and low ventilation from all parts of the lung, in all phases of the breath.

4DX Intrinsic Value
0.35 AUD
Undervaluation 29%
Intrinsic Value
Price
Back to Top